IFF · International Flavors & Fragrances Inc

$87.95 +1.10 (+1.27%) At close · Aug 28

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$22.16B

255.15M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$10.89B -5.2%

FY2025

Net Income

-$359M -234.5%

FY2025

Gross Margin

36.16% +0.2pp

FY2025

Operating Margin

-3.51% -10.2pp

FY2025

Diluted EPS

-$1.41 -235.6%

FY2025

Operating Cash Flow

$850M -20.6%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow Adjusted All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Revenue	-4.3%	+16.5%	—	$7.4B – $7.6B	$10.82B	$10.89B^G	$11.48B^G	$11.48B^G	$12.44B	$11.66B	$5.08B	$5.14B	$3.98B	$3.4B	$3.12B	—	—	—	—	—	—	—	—
Cost of Revenue	-5.7%	+18.3%	+15.3%	—	$6.87B	$6.95B	$7.36B	$7.8B	$8.29B	$7.92B	$3B	$3.03B	$2.29B	$1.93B	$1.72B	$1.67B	$1.73B	$1.67B	$1.65B	$1.68B	$1.53B	$1.39B	$1.42B
Gross Profit	-1.7%	+13.6%	+11.3%	—	$3.95B	$3.94B	$4.12B	$3.68B	$4.15B	$3.74B	$2.09B	$2.11B	$1.68B	$1.47B	$1.4B	$1.35B	$1.36B	$1.28B	$1.18B	—	—	—	—
Gross Margin	—	—	—	—	—	36.16%	35.91%	32.07%	33.37%	32.04%	41.03%	41.11%	42.31%	43.32%	44.78%	—	—	—	—	—	—	—	—
Research & Development	+4.8%	+14.2%	+10.9%	—	$696M	$694M	$671M	$636M	$603M	$629M	$357M	$346M	$311.58M	$295.47M	$258.86M	$246.1M	$253.64M	$259.84M	$233.71M	$219.78M	$218.77M	$184.77M	$196.86M
Selling, General & Administrative	+1.2%	+14.1%	+14.0%	—	$1.83B	$1.83B	$2B	$1.79B	$1.77B	$1.75B	$949M	$876M	$707.46M	$570.14M	$572.52M	$494.52M	$507.56M	$505.88M	$453.54M	$443.97M	$447.39M	$390.89M	$400.72M
Amortization of Intangibles	-7.9%	+24.1%	+43.8%	—	$571M	$568M	$610M	$680M	$727M	$732M	$193M	$193M	$75.88M	$34.69M	$23.76M	$15.04M	$7.33M	$6.1M	$6.1M	$6.1M	$6.1M	—	—
Depreciation & Amortization	-6.6%	+24.2%	+26.8%	—	$948M	$962M	$1.02B	$1.14B	$1.18B	$1.16B	$325M	$323M	$173.79M	$117.97M	$102.47M	$89.6M	$89.35M	$83.23M	$76.67M	$75.33M	$79.24M	$78.53M	$75.99M
Restructuring Charges	+80.0%	+32.7%	+24.9%	—	$45M	$70M	$29M	$68M	$12M	$41M	$17M	$30M	$5.08M	$19.71M	-$1.04M	$7.59M	$6.4M	$7.4M	$1.67M	$13.17M	$10.08M	$18.3M	$18.21M
Total Costs & Expenses	+2.9%	+3.2%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$2.47B	$2.38B	$2.41B	$2.26B	$2.05B	$2.11B
Operating Income	—	—	—	—	$810M	-$382M	$766M	-$2.11B	-$1.33B	$585M	$566M	$665M	$583.88M	$552.63M	$552.96M	$588.35M	$592.32M	$516.34M	$486.62M	$427.73M	$416.36M	$340.29M	—
Operating Margin	—	—	—	—	—	-3.51%	6.67%	-18.38%	-10.66%	5.02%	11.13%	12.94%	14.68%	16.26%	17.74%	—	—	—	—	—	—	—	—
EBITDA	—	-8.2%	-1.5%	—	$1.76B	$580M	$1.78B	-$968M	-$147M	$1.74B	$891M	$988M	$757.67M	$670.6M	$655.42M	$677.94M	$681.68M	$599.57M	$563.29M	$503.06M	$495.6M	$418.81M	—
Interest Expense	-12.0%	+11.6%	+17.4%	—	$187M	$229M	$305M	$380M	$336M	$289M	$132M	$138M	$132.56M	$65.36M	$52.99M	$46.06M	$46.07M	$46.77M	$41.75M	$44.64M	$48.71M	$61.82M	$74.01M
Interest Income	+8.2%	—	—	—	$15M	$19M	$15M	$5M	$15M	$8M	—	—	—	—	—	—	—	—	—	—	—	—	—
Other Non-Operating Income	—	—	—	—	-$58M	-$65M	-$182M	-$5M	$26M	$58M	$7M	$30M	$35.24M	$49.78M	$23.75M	-$3.18M	$2.81M	$15.64M	-$1.45M	-$9.54M	-$8.06M	-$1.92M	$2.8M
Pretax Income	—	—	—	—	$417M	-$412M	$308M	-$2.52B	-$1.63B	$354M	$441M	$557M	$447.76M	$537.05M	$523.72M	$539.1M	$549.06M	$485.21M	$443.42M	$373.55M	$359.59M	$276.55M	$283.92M
Income Tax	—	—	—	—	$106M	-$53M	$41M	$69M	$239M	$75M	$74M	$97M	$107.98M	$241.38M	$118.69M	$119.85M	$134.52M	$131.67M	$189.28M	$106.68M	$96.04M	$81.02M	$54.29M
Net Income	—	—	—	—	$279M	-$359M	$267M	-$2.59B	-$1.86B	$279M	$367M	$460M	$339.78M	$295.67M	$405.03M	$419.25M	$414.54M	$353.54M	$254.13M	$266.87M	$263.56M	$195.53M	$229.63M
Net Margin	—	—	—	—	—	-3.3%	2.32%	-22.54%	-14.98%	2.39%	7.22%	8.95%	8.54%	8.7%	13%	—	—	—	—	—	—	—	—
Net Income Attributable to Noncontrolling Interests	-34.1%	-12.9%	—	—	$2M	$2M	$4M	$4M	$7M	$9M	$4M	$4M	$2.48M	$0	$0	—	—	—	—	—	—	—	—
Net Income Available to Common Stockholders	—	—	—	—	—	-$361M	$263M	-$2.59B	-$1.87B	$270M	$363M	$456M	$337.3M	$295.67M	$405.03M	—	—	—	—	—	—	—	—
Comprehensive Income	—	+14.0%	+7.8%	—	$105M	$736M	-$368M	-$2.29B	-$2.65B	-$455M	$382M	$441M	$272.56M	$338.28M	$338.38M	$346.24M	$266.82M	$364.46M	$225.82M	$166.91M	$259.18M	$249.66M	$48.87M
EPS (Basic) USD/shares	—	—	—	—	$1.09	-$1.41	$1.04	-$10.14	-$7.32	$1.11	$3.25	$4.05	$3.81	$3.73	$5.07	$5.19	$5.09	$4.32	$3.11	$3.30	$3.29	$2.48	$2.89
EPS (Diluted) USD/shares	—	—	—	—	$1.10	-$1.41	$1.04	-$10.14	-$7.32	$1.10	$3.21	$4.00	$3.79	$3.72	$5.05	$5.16	$5.06	$4.29	$3.09	$3.26	$3.26	$2.46	$2.86
Shares Outstanding (Basic Avg) shares	+0.1%	+18.0%	+12.3%	—	—	256M	256M	255M	255M	243M	112M	112M	87.55M	79.07M	79.65M	80.45M	80.94M	81.32M	81.11M	80.46M	79.5M	78.4M	—
Shares Outstanding (Diluted Avg) shares	+0.1%	+17.6%	+12.2%	—	—	256M	256M	255M	255M	243M	114M	113M	88.12M	79.37M	79.98M	80.89M	81.49M	81.93M	81.83M	81.47M	80.44M	79.09M	—

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $532.71M in buybacks, $5.32B in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

2.51×

Peer median 2.40×

EV/EBIT

33.59×

Peer median 26.03×

P/E (TTM)

78.95×

Peer median 29.39×

EV/Adj. EBITDA (FY2026)

13.23×

Peer median 11.86×

Peer medians compare against the 29 similar-size Specialty Chemicals companies (of 62 listed).

EV/Adj. EBITDA uses the company-stated “Credit Adjusted EBITDA”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.

Valuation over time computed as of each quarter's filing date

EV/Adj. EBITDA uses the company-stated “Credit Adjusted EBITDA”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Food Ingredients	$3,278,000,000	$3,365,000,000	$3,692,000,000	—	—	—	—	—
Taste	$2,481,000,000	$2,428,000,000	$2,303,000,000	—	—	—	—	—
Scent	$2,479,000,000	$2,439,000,000	$2,393,000,000	$2,301,000,000	$2,254,000,000	$2,064,000,000	$2,033,000,000	—
Health and Biosciences	$2,283,000,000	$2,203,000,000	$2,071,000,000	$2,339,000,000	—	—	—	—
Pharma Solutions	$369,000,000	$1,049,000,000	$1,020,000,000	$971,000,000	$809,000,000	$0	$0	—
Flavors	—	—	—	—	—	—	—	$2,091,635,000
Fragrances	—	—	—	—	—	—	—	$1,885,904,000
Frutarom Industries Ltd.	—	—	—	—	—	—	—	$359,560,000
Health Biosciences	—	—	—	—	$2,329,000,000	$134,000,000	$129,000,000	—
Nourish	—	—	—	$6,829,000,000	$6,264,000,000	$2,886,000,000	$2,978,000,000	—

By Geography (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
EMEA	$3,727,000,000	$3,840,000,000	$3,834,000,000	$4,219,000,000	$4,093,000,000	$1,987,000,000	$2,082,000,000	$1,396,316,000
North America	$3,195,000,000	$3,440,000,000	$3,477,000,000	$3,853,000,000	$3,499,000,000	$1,228,000,000	$1,170,000,000	$1,010,126,000
Asia	$2,546,000,000	$2,731,000,000	$2,677,000,000	$2,876,000,000	$2,728,000,000	$1,162,000,000	$1,163,000,000	$991,015,000
Latin America	$1,422,000,000	$1,473,000,000	$1,491,000,000	$1,492,000,000	$1,336,000,000	$707,000,000	$725,000,000	$580,082,000

By Product & Service (USD)

Component	FY2020	FY2019	FY2018	FY2017
Flavor Compounds	$2,737,079,000	—	—	—
Fragrance Compounds	$1,577,528,000	—	—	—
Fragrance Ingredients	$396,930,000	$745,752,000	$490,061,000	$341,941,000
Flavor Ingredients	$372,702,000	—	—	—
Flavors	—	$2,850,498,000	$1,990,985,000	$1,632,166,000
Fragrances	—	$1,543,834,000	$1,496,493,000	$1,424,612,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component	FY2020	FY2019	FY2018	FY2017
Flavors	$436,387,000	$482,394,000	$419,264,000	$360,483,000
Fragrances	$357,281,000	$349,445,000	$325,901,000	$318,954,000
Frutarom Industries Ltd.	—	$126,804,000	$27,358,000	—

Operating Margin by Segment (%)

Component	FY2018
Flavors	20%
Fragrances	17.3%
Frutarom Industries Ltd.	7.6%

Key facts CIK 51253 CUSIP 459506101 13F (30d) 540 filings 518 filers Visit website Investor relations